Bioceres Crop Solutions Corp (BIOX)
Official siteBASIC MATERIALS • AGRICULTURAL INPUTS • NASDAQ
Market Cap: $13.40M
Last updated: Nov 17, 2026 at 10:59 AM ET
Bioceres Crop Solutions Corp (BIOX) Financials: Revenue, Profit and Cash Flow
Bioceres Crop Solutions reported revenue of $237.80M for the fiscal year ended Jun 30, 2026, down 28.7% from the year before. That year, net income was -$230.30M with a net margin of -96.8%, operating cash flow was $52.60M and free cash flow was $51.55M. The quarter ended Jun 30, 2026 had revenue of $57.00M and net income of -$27.50M.
Revenue and Margins
The operating margin was 0.0% in the fiscal year ended Jun 2026. Over the 9 years to Jun 2026, revenue grew from $93.71M, a compound annual rate of 10.9%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Jun 2026 | $237.80M | -28.7% | 34.7% | 0.0% | -96.8% |
| Jun 2025 | $333.34M | -28.3% | 38.4% | -0.2% | -16.6% |
| Jun 2024 | $464.83M | +10.8% | 39.1% | 9.6% | 0.7% |
| Jun 2023 | $419.45M | -99.9% | 43.9% | 12.6% | 4.5% |
| Jun 2022 | $328.46B | +158806.3% | 36.6% | 11.8% | -2.2% |
| Jun 2021 | $206.70M | +19.9% | 44.0% | 18.6% | -3.3% |
| Jun 2020 | $172.35M | +7.5% | 46.1% | 22.7% | 1.9% |
| Jun 2019 | $160.31M | +20.1% | 45.9% | 20.0% | -11.5% |
| Jun 2018 | $133.49M | +42.5% | 42.2% | 11.8% | -8.3% |
| Jun 2017 | $93.71M | N/A | 36.1% | -0.8% | -12.6% |
Income Statement
In the fiscal year ended Jun 2026, the net loss widened from the year before. In the quarter ended Jun 2026, the net loss narrowed from the same quarter a year earlier.
Annual
| Line item | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $237.80M | $333.34M | $464.83M | $419.45M | $328.46B | $206.70M | $172.35M | $160.31M | $133.49M | $93.71M |
| Cost of revenue | $155.40M | $205.19M | $283.24M | $235.46M | $208.36B | $115.82M | $92.86M | $86.68M | $77.09M | $59.86M |
| Gross profit | $82.40M | $128.15M | $181.59M | $183.99M | $120.09B | $90.88M | $79.49M | $73.62M | $56.40M | $33.85M |
| Research and development | $11.03M | $14.91M | $17.18M | $15.35M | $6.95B | $5.62M | $4.20M | $3.69M | $3.95M | $3.98M |
| Operating income | $100.00K | -$761.90K | $44.82M | $52.99M | $38.73B | $38.38M | $39.15M | $32.09M | $15.71M | -$706.92K |
| Net income | -$230.30M | -$55.42M | $3.24M | $18.78M | -$7.20B | -$6.87M | $3.36M | -$18.37M | -$11.04M | -$11.82M |
| EBITDA | $100.00K | N/A | $55.46M | $62.28M | $39.88B | $43.70M | N/A | N/A | N/A | $3.90M |
Quarterly
| Line item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $57.00M | $38.20M | $73.67M | $77.44M | $74.40M | $59.60M | $98.88M | $92.62M | $124.31M | $84.00M | $140.30M | $116.18M |
| Gross profit | $13.80M | $11.50M | $26.31M | $35.64M | $24.20M | $23.47M | $41.32M | $37.24M | $46.07M | $42.60M | $51.50M | $43.53M |
| Operating income | -$10.10M | -$6.50M | $7.82M | $7.76M | -$14.90M | $933.21K | $15.19M | $3.66M | $9.48M | $13.20M | $16.80M | $5.29M |
| Net income | -$27.50M | -$12.30M | -$183.04M | -$7.33M | -$44.30M | -$1.30M | $143.53K | -$6.37M | -$1.53M | $9.26M | $108.45K | -$4.59M |
Balance Sheet
As of Jun 2026, total debt of $227.98M exceeded cash and equivalents by $216.78M.
Annual
| Line item | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $471.30M | $763.65M | $852.55M | $818.06M | $518.22M | $394.59M | $297.56M | $242.47M | $196.64M | $239.87M |
| Current assets | $215.20M | $308.31M | $408.67M | $397.11M | $297.71M | $211.49M | $164.69M | $98.21M | $85.34M | $87.77M |
| Cash and equivalents | $11.20M | $32.70M | $44.47M | $48.13M | $33.48M | $36.05M | $27.16M | $3.45M | $2.22M | $1.68M |
| Total liabilities | $407.20M | $468.43M | $501.17M | $487.56M | $359.92M | $304.30M | $237.51M | $180.37M | $163.51M | $160.13M |
| Short-term debt | $168.00M | $228.88M | $139.87M | $111.50M | $72.71M | $77.54M | $64.39M | $66.48M | $65.31M | $34.04M |
| Long-term debt | $59.98M | $38.20M | $122.91M | $135.88M | $135.90M | $86.74M | $96.65M | $84.26M | $25.71M | $40.95M |
| Shareholder equity | $39.10M | $262.81M | $315.30M | $298.85M | $127.61M | $67.74M | $45.48M | $47.30M | $33.13M | $38.34M |
Quarterly
| Line item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $471.30M | $529.60M | $560.36M | $734.88M | $763.65M | $798.21M | $835.20M | $827.26M | $850.63M | $836.13M | $817.20M | $819.70M |
| Total liabilities | $407.20M | $439.70M | $453.75M | $455.83M | $468.43M | $453.24M | $488.87M | $481.23M | $501.06M | $487.60M | $482.00M | $496.36M |
| Cash and equivalents | $11.20M | $14.40M | $11.06M | $15.51M | $32.70M | $38.46M | $29.18M | $32.28M | $44.47M | $16.36M | $24.40M | $28.37M |
| Shareholder equity | $39.10M | $63.80M | $73.77M | $249.38M | $262.81M | $308.71M | $309.81M | $309.74M | $314.01M | $313.35M | $300.50M | $289.68M |
Cash Flow
In the fiscal year ended Jun 2026, free cash flow was 98.0% of operating cash flow.
Annual
| Line item | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $52.60M | $49.91M | $41.72M | $2.59M | -$17.52M | -$6.21M | $9.32M | $29.69M | $18.39M | $19.10M |
| Capital expenditures | $1.05M | $14.61M | $22.78M | $22.56M | $9.00M | $13.92M | $4.50M | $3.45M | $5.71M | $1.39M |
| Free cash flow | $51.55M | $35.30M | $18.93M | -$19.97M | -$26.51M | -$20.13M | $4.82M | $26.25M | $12.68M | $17.71M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 | $1.03M | $0 | $0 | $0 | $0 |
| Investing cash flow | -$5.86M | -$6.13M | -$28.73M | -$25.73M | $2.90M | -$8.31M | -$7.80M | -$3.26M | -$8.22M | -$20.16M |
| Financing cash flow | -$65.30M | -$50.71M | -$10.06M | $32.95M | $14.82M | $7.36M | $33.53M | -$26.95M | -$10.46M | $2.33M |
Quarterly
| Line item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | N/A | N/A | $17.39M | $14.38M | $26.77M | $23.34M | -$5.36M | $5.16M | $23.26M | -$17.39M | $21.12M | $14.73M |
| Capital expenditures | $0 | $0 | $216.11K | $1.37M | $2.18M | $5.91M | $3.38M | $3.14M | $2.02M | $5.98M | $4.75M | $6.00M |
| Free cash flow | N/A | N/A | $17.17M | $13.01M | $24.59M | $17.43M | -$8.73M | $2.02M | $21.24M | -$23.37M | $16.37M | $8.74M |
Frequently Asked Questions About BIOX
What is Bioceres Crop Solutions' annual revenue?
Bioceres Crop Solutions reported revenue of $237.80M for the fiscal year ended Jun 30, 2026.
How fast is Bioceres Crop Solutions' revenue growing?
Revenue was down 28.7% for the fiscal year ended Jun 30, 2026 compared with the year before. The compound annual revenue growth rate over 3 years was -17.2%.
Is Bioceres Crop Solutions profitable?
No. Bioceres Crop Solutions reported net income of -$230.30M for the fiscal year ended Jun 30, 2026, with a net margin of -96.8%.
How much free cash flow does BIOX generate?
For the fiscal year ended Jun 30, 2026, operating cash flow of $52.60M minus capital expenditures of $1.05M produced free cash flow of $51.55M.
How much debt does Bioceres Crop Solutions have?
The balance sheet dated Jun 30, 2026 reported long-term debt of $59.98M, short-term debt of $168.00M and cash and equivalents of $11.20M.
BIOX pages: Overview, Earnings, Financials, Valuation